Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)

Manufacturer
Haemonetics Corporation | Haemonetics Manufacturing Inc
Effective date
2022-06-13
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:59:25

Label at a glance#

ProductLeukotrap - CP2D
Active ingredientDEXTROSE, UNSPECIFIED FORM
Label structure2 sections

Label contents#

Full prescribing information#

HOW SUPPLIED SECTION

How Supplied: 250 mL CP2D Anticoagulant Solution is supplied in flexible PVC containers with a sterile, non-pyrogenic fluid path. 250 mL and 300 mL AS-3 Nutrient Solution is supplied in flexible PVC containers with a sterile, non-pyrogenic fluid path.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANELPRINCIPAL DISPLAY PANEL

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53157-45553157-455-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2cdf0ae6-e6cb-d4c1-e063-6294a90aed1be154f8b7-89a0-dfbb-e053-2995a90a300a2025-01-29Exact identifier
spl set id: e154f8b7-89a0-dfbb-e053-2995a90a300a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.